Literature DB >> 25679302

Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association.

Alexander Kulik, Marc Ruel, Hani Jneid, T Bruce Ferguson, Loren F Hiratzka, John S Ikonomidis, Francisco Lopez-Jimenez, Sheila M McNallan, Mahesh Patel, Véronique L Roger, Frank W Sellke, Domenic A Sica, Lani Zimmerman.   

Abstract

Keywords:  AHA Scientific Statements; coronary artery bypass grafting; prevention and control; risk-reduction behavior

Mesh：

Year:  2015        PMID： 25679302     DOI： 10.1161/CIR.0000000000000182

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  79 in total

1.  The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial.

Authors:  Bert Andersson; Lilin She; Ru-San Tan; Panniyammakal Jeemon; Krzysztof Mokrzycki; Matthias Siepe; Alexander Romanov; Liliana E Favaloro; Ljubomir T Djokovic; P Krishnam Raju; Piotr Betlejewski; Normand Racine; Adam Ostrzycki; Weerachai Nawarawong; Siuli Das; Jean L Rouleau; George Sopko; Kerry L Lee; Eric J Velazquez; Julio A Panza
Journal:  Eur Heart J       Date:  2018-10-01       Impact factor: 29.983

2.  Pre-operative use of aspirin in patients undergoing coronary artery bypass grafting: a systematic review and updated meta-analysis.

Authors:  Karla Solo; Shahar Lavi; Tawfiq Choudhury; Janet Martin; Immaculate F Nevis; Chun Shing Kwok; Rafail A Kotronias; Natsumi Nishina; Sandro Sponga; Diana Ayan; Nikolaos Tzemos; Mamas A Mamas; Rodrigo Bagur
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 3.  Aspirin Use Prior to Coronary Artery Bypass Grafting Surgery: a Systematic Review.

Authors:  Ayman Elbadawi; Marwan Saad; Ramez Nairooz
Journal:  Curr Cardiol Rep       Date:  2017-02       Impact factor: 2.931

Review 4.  Assessing Performance and Quality After Non-ST Segment Elevation Acute Coronary Syndromes.

Authors:  H Vernon Anderson; Robin Jacob
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

5.  Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry.

Authors:  Angela Lowenstern; Jingjing Wu; Steven M Bradley; Alexander C Fanaroff; James E Tcheng; Tracy Y Wang
Journal:  Am Heart J       Date:  2019-06-28       Impact factor: 4.749

6.  Extracellular Matrix for Small-Diameter Vascular Grafts.

Authors:  Megan Kimicata; Prateek Swamykumar; John P Fisher
Journal:  Tissue Eng Part A       Date:  2020-12       Impact factor: 3.845

7.  Hospital Variability Drives Inconsistency in Antiplatelet Use After Coronary Bypass.

Authors:  Jared P Beller; William Z Chancellor; J Hunter Mehaffey; Robert B Hawkins; Matthew R Byler; Alan M Speir; Mohammed A Quader; Andy C Kiser; Leora T Yarboro; Gorav Ailawadi; Nicholas R Teman
Journal:  Ann Thorac Surg       Date:  2020-02-11       Impact factor: 4.330

8.  Assessment of decellularized pericardial extracellular matrix and poly(propylene fumarate) biohybrid for small-diameter vascular graft applications.

Authors:  Megan Kimicata; Jules D Allbritton-King; Javier Navarro; Marco Santoro; Takahiro Inoue; Narutoshi Hibino; John P Fisher
Journal:  Acta Biomater       Date:  2020-04-16       Impact factor: 8.947

Review 9.  Biomaterial-Based Approaches to Address Vein Graft and Hemodialysis Access Failures.

Authors:  Timothy C Boire; Daniel A Balikov; Yunki Lee; Christy M Guth; Joyce Cheung-Flynn; Hak-Joon Sung
Journal:  Macromol Rapid Commun       Date:  2016-09-27       Impact factor: 5.734

10.  Epiaortic Ultrasound for Assessment of Intraluminal Atheroma; Insights from the REGROUP Trial.

Authors:  Alexander D Shapeton; Kay B Leissner; Suzana M Zorca; Houman Amirfarzan; Eileen M Stock; Kousick Biswas; Miguel Haime; Venkatesh Srinivasa; Jacquelyn A Quin; Marco A Zenati
Journal:  J Cardiothorac Vasc Anesth       Date:  2019-11-09       Impact factor: 2.628
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.